Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors.
Inamoto T, Yamada T, Ohnuma K, Kina S, Takahashi N, Yamochi T, Inamoto S, Katsuoka Y, Hosono O, Tanaka H, Dang NH, Morimoto C.
Clin Cancer Res. 2007 Jul 15;13(14):4191-200.PMID: 17634548 [PubMed - indexed for MEDLINE]Free ArticleRelated citations